Charles River Laboratories International, Inc. (CRL)
298.58
+3.39
(+1.15%)
USD |
NYSE |
Aug 24, 16:00
298.74
+0.16
(+0.05%)
Pre-Market: 20:00
Charles River Laboratories International Profit Margin (Quarterly) : -0.08% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.08% |
| March 31, 2026 | -1.49% |
| December 31, 2025 | -27.79% |
| September 30, 2025 | 5.53% |
| June 30, 2025 | 5.11% |
| March 31, 2025 | 2.63% |
| December 31, 2024 | -21.32% |
| September 30, 2024 | 6.96% |
| June 30, 2024 | 9.19% |
| March 31, 2024 | 7.36% |
| December 31, 2023 | 18.64% |
| September 30, 2023 | 8.57% |
| June 30, 2023 | 9.38% |
| March 31, 2023 | 10.10% |
| December 31, 2022 | 17.19% |
| September 30, 2022 | 9.87% |
| June 30, 2022 | 11.37% |
| March 31, 2022 | 10.42% |
| December 31, 2021 | 15.45% |
| September 30, 2021 | 11.74% |
| June 30, 2021 | 9.83% |
| March 31, 2021 | 7.75% |
| December 31, 2020 | 18.23% |
| September 30, 2020 | 13.80% |
| June 30, 2020 | 9.91% |
| Date | Value |
|---|---|
| March 31, 2020 | 7.19% |
| December 31, 2019 | 11.65% |
| September 30, 2019 | 11.01% |
| June 30, 2019 | 6.74% |
| March 31, 2019 | 9.21% |
| December 31, 2018 | 10.01% |
| September 30, 2018 | 10.41% |
| June 30, 2018 | 9.03% |
| March 31, 2018 | 10.78% |
| December 31, 2017 | -6.07% |
| September 30, 2017 | 11.42% |
| June 30, 2017 | 11.65% |
| March 31, 2017 | 10.54% |
| December 31, 2016 | 9.70% |
| September 30, 2016 | 8.85% |
| June 30, 2016 | 8.19% |
| March 31, 2016 | 10.59% |
| December 31, 2015 | 9.40% |
| September 30, 2015 | 10.85% |
| June 30, 2015 | 14.50% |
| March 31, 2015 | 9.87% |
| December 31, 2014 | 8.66% |
| September 30, 2014 | 9.86% |
| June 30, 2014 | 10.69% |
| March 31, 2014 | 10.90% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 5.90% |
| Medpace Holdings, Inc. | 17.16% |
| Fortrea Holdings, Inc. | -1.95% |
| Avantor, Inc. | 2.25% |
| Champions Oncology, Inc. | -4.82% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -7.41% |
| Return on Assets | -3.15% |
| Return on Invested Capital | -3.93% |
| Gross Profit Margin (Quarterly) | 36.29% |
| Operating Margin (Quarterly) | 14.96% |
| Return on Net Operating Assets | -3.51% |